Clinical trial
Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating…
NCT00255918 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00255918 |
|---|---|
| Title | Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients |
| Official title | Phase 1 Trial of 3-2,4 Dimethoxbenzylidene Anabaseine in Schizophrenia |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | Dimethoxybenzylidene anabaseine (DMXB-A), Placebo |
| Enrollment | 12 |
| Start date | Mar 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Nov 21, 2005 |
| Last update posted | Jul 1, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: